Description
Seeking women 18 years or older with confirmed ovarian cancer who have previously received treatment, for participation in a study of an investigational drug for subjects with recurrent ovarian cancer that has failed previous treatment
Overview
We are studying the effects of an investigatory drug called Pembrolizumab or placebo, in combination other standard of care drugs for participants with recurrent ovarian cancer to determine how safe it is and how well it works for this type of cancer. Evaluate the safety of Pembrolizumab compared to the standard of care in participants with recurrent ovarian cancer.
What we're hoping for
Evaluate the safety of Pembrolizumab and how well it works compared to the standard of care in participants with recurrent ovarian cancer.
Additional Information
ClinicalTrials.gov Identifier: NCT05116189